Latest Darwin Global Management, Ltd. Stock Portfolio
About Darwin Global Management, Ltd. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Darwin Global Management, Ltd. reported an equity portfolio of $1.2 Billions as of 30 Sep, 2024.
The top stock holdings of Darwin Global Management, Ltd. are INSM, PCVX, GERN. The fund has invested 62.3% of it's portfolio in INSMED INC and 20.4% of portfolio in VAXCYTE INC.
The fund managers got completely rid off CYTOKINETICS INC (CYTK), CORBUS PHARMACEUTICALS HLDGS (CRBP) and SPYRE THERAPEUTICS INC (AGLE) stocks. They significantly reduced their stock positions in GERON CORP (GERN) and KEROS THERAPEUTICS INC (KROS). Darwin Global Management, Ltd. opened new stock positions in SUMMIT THERAPEUTICS INC (SMMT). The fund showed a lot of confidence in some stocks as they added substantially to INSMED INC (INSM) and VAXCYTE INC (PCVX).
The top stock holdings of Darwin Global Management, Ltd. are INSM, PCVX, GERN. The fund has invested 62.3% of it's portfolio in INSMED INC and 20.4% of portfolio in VAXCYTE INC.
The fund managers got completely rid off CYTOKINETICS INC (CYTK), CORBUS PHARMACEUTICALS HLDGS (CRBP) and SPYRE THERAPEUTICS INC (AGLE) stocks. They significantly reduced their stock positions in GERON CORP (GERN) and KEROS THERAPEUTICS INC (KROS). Darwin Global Management, Ltd. opened new stock positions in SUMMIT THERAPEUTICS INC (SMMT). The fund showed a lot of confidence in some stocks as they added substantially to INSMED INC (INSM) and VAXCYTE INC (PCVX).
Darwin Global Management, Ltd. Annual Return Estimates Vs S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| summit therapeutics inc | 23,758,900 |
New stocks bought by Darwin Global Management, Ltd.
Additions
| Ticker | % Inc. |
|---|---|
| insmed inc | 196 |
| vaxcyte inc | 5.63 |
Additions to existing portfolio by Darwin Global Management, Ltd.
Reductions
| Ticker | % Reduced |
|---|---|
| geron corp | -7.85 |
| keros therapeutics inc | -0.14 |
Darwin Global Management, Ltd. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cytokinetics inc | -246,074,000 |
| elevation oncology inc | -4,809,890 |
| spyre therapeutics inc | -10,265,800 |
| corbus pharmaceuticals hldgs | -14,267,100 |
| avidity biosciences inc | -8,108,000 |
Darwin Global Management, Ltd. got rid off the above stocks
Sector Distribution
| Sector | % |
|---|---|
| Healthcare | 100 |
Market Cap. Distribution
| Category | % |
|---|---|
| LARGE-CAP | 62.3 |
| MID-CAP | 28.6 |
| SMALL-CAP | 9.1 |
Stocks belong to which Index?
| Index | % |
|---|---|
| RUSSELL 2000 | 100 |
Darwin Global Management, Ltd. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Darwin Global Management, Ltd.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ELEV | elevation oncology inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GERN | geron corp | 8.14 | 22,038,800 | 100,056,000 | reduced | -7.85 | ||
| INSM | insmed inc | 62.31 | 10,497,300 | 766,301,000 | added | 196 | ||
| KROS | keros therapeutics inc | 7.20 | 1,523,730 | 88,483,100 | reduced | -0.14 | ||
| PCVX | vaxcyte inc | 20.42 | 2,198,190 | 251,187,000 | added | 5.63 | ||
| RNA | avidity biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SMMT | summit therapeutics inc | 1.93 | 1,084,880 | 23,758,900 | new | |||